#USA #New York #Public Offering #EQT VIII #Waystar Holding

EQT Successfully Completes Public Offering of Waystar Holding Corp.

EQT, through its affiliate EQT VIII, has successfully concluded an underwritten public offering of approximately 14.4 million shares of common stock for Waystar Holding Corp. (NASDAQ: WAY). This significant event, finalized on May 20, 2025, is expected to bolster the company's financial standing and expand its capital base.

The offering generated total gross proceeds of around $557 million, with EQT itself benefiting from roughly $239.6 million from the sale of 6.2 million shares. The successful completion of this public offering highlights both the solid interest in Waystar's stock and the confidence investors hold in its long-term potential.

This offering also included the full exercise of underwriters’ options which permitted the purchase of an additional 1.9 million shares, demonstrating strong demand from the market. Major financial institutions including J.P. Morgan, Goldman Sachs, and Barclays acted as joint book-running managers overseeing the offering process.

It's important to note that while EQT profited from its share sales, the company itself did not sell any shares during the offering period nor did it receive any proceeds from other stockholders' sales. This move aligns with EQT's strategic objectives to support Waystar's growth while maximizing returns for its investors.

Waystar has established itself as a cutting-edge health technology company, focusing on streamlining healthcare administration and providing innovative solutions to improve financial health across stakeholders in the sector. The successful launch of this public offering will empower the company to further its pioneering initiatives, invest in product development, and enhance operational excellence.

Summary of Offering Details

• - Total shares sold: Approximately 14.4 million
• - Total gross proceeds: Approximately $557 million
• - EQT’s proceeds: Approximately $239.6 million from its share sale.
• - Advisors: J.P. Morgan, Goldman Sachs, and Barclays.

The completion of this offering marks a significant milestone for EQT VIII, positioning them well for future investments and financial maneuvering within the market. As investors turn their attention to healthcare innovation, EQT's role in facilitating Waystar’s expansion could yield further opportunities, fostering advancements in healthcare technology and financial solutions which remains a priority for stakeholders across the industry.

As we observe the evolving landscape of healthcare finance, this public offering underscores the importance of strategic investments in ambitious companies such as Waystar, which aim not only for profitability but also for transformative impacts across health administration practices.